Last reviewed · How we verify

Ketoconazole 2% Shampoo

Fakultas Kedokteran Universitas Indonesia · FDA-approved active Small molecule

Ketoconazole inhibits fungal cytochrome P450 enzymes, disrupting ergosterol synthesis in fungal cell membranes and causing cell death.

Ketoconazole inhibits fungal cytochrome P450 enzymes, disrupting ergosterol synthesis in fungal cell membranes and causing cell death. Used for Seborrheic dermatitis of the scalp, Dandruff, Tinea versicolor (pityriasis versicolor).

At a glance

Generic nameKetoconazole 2% Shampoo
Also known asNizoral
SponsorFakultas Kedokteran Universitas Indonesia
Drug classImidazole antifungal
TargetFungal cytochrome P450 (CYP51 / lanosterol 14α-demethylase)
ModalitySmall molecule
Therapeutic areaDermatology
PhaseFDA-approved

Mechanism of action

Ketoconazole is an imidazole antifungal that blocks the fungal enzyme lanosterol 14α-demethylase (CYP51), a key step in ergosterol biosynthesis. This disrupts the integrity of the fungal cell membrane, leading to leakage of cellular contents and fungal cell death. The 2% shampoo formulation delivers the drug topically to the scalp for local antifungal activity.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: